Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Assess top-performing Hyd etfs for retirees, comparing yields, risk, and track records to help you choose a fund aligned with retirement goals.
27,995 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Strategy faces an $8 billion cash wall over the next two years as STRC trades well below par, sharpening questions ab...
A leading economist contends the FED will keep rates steady through year-end, challenging current market bets and sha...
Could Bloom Energy ride AI demand like Nvidia did? This comprehensive guide weighs the parallels, the risks, and prac...
Qualcomm's AI data-center push is fueling a fresh round of upside bets, with investors watching for a sustained ramp ...
A California avalanche during a guided backcountry trek left eight dead and one missing. The trip carried 15 skiers w...
The world economic forum head Børge Brende resigned Thursday amid scrutiny over ties to Jeffrey Epstein. An independe...
Trump urges Congress move on crypto rules amid a banking clash, signaling a push for a clearer framework. This piece ...
Mega-cap tech names are offering ballast as markets wobble, but the rally is fragile and depends on earnings momentum...
A veteran executive coach shows how Beat the Plan helps Fortune 500 leaders cut decision time, improve quality, and s...
Investors await Federal Reserve Chair Jerome Powell's remarks as U.S. markets drift higher on rising oil prices. Anal...
Two major AI infrastructure players appear attractively priced as heavy investment in AI chips and automation presses...